These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18302719)

  • 1. Influence of bone marrow nucleated red blood cell dose on outcome after allogeneic haematopoietic stem cell transplantation.
    Robin M; Kernèis S; Porcher R; de Latour RP; Traineau R; Ribaud P; Rocha V; Devergie A; Marolleau JP; Benburan M; Socié G; Larghero J
    Br J Haematol; 2008 Mar; 140(6):725-7. PubMed ID: 18302719
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Umbilical cord blood for replacement of bone marrow for allogeneic transplantation of hematopoietic stem cells. Stichting Eurocord Nederland].
    Falkenburg JH; Lim FT
    Ned Tijdschr Geneeskd; 1995 Jul; 139(26):1319-22. PubMed ID: 7617048
    [No Abstract]   [Full Text] [Related]  

  • 4. Ex vivo fucosylation of stem cells to improve engraftment: WO2004094619.
    Taupin P
    Expert Opin Ther Pat; 2010 Sep; 20(9):1265-9. PubMed ID: 20518619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation.
    Choudhry VP
    Indian Pediatr; 1997 Jun; 34(6):505-17. PubMed ID: 9357206
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of hematologic disorders with stem cell transplantation].
    Hirai H
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():141-6. PubMed ID: 11989254
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of clinical experience in umbilical cord blood transplantation].
    Fernández MN
    Sangre (Barc); 1997 Apr; 42(2):135-40. PubMed ID: 9297261
    [No Abstract]   [Full Text] [Related]  

  • 8. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
    Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
    Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathology of bone marrow reconstitution after umbilical cord blood transplantation for hematological diseases.
    Maeda T; Shiozawa E; Mayumi H; Usui T; Nakashima H; Hattori N; Adachi D; Saito B; Yanagisawa K; Matsuda I; Nakamaki T; Tomoyasu S; Yamochi-Onizuka T; Takimoto M; Ota H
    Pathol Int; 2008 Feb; 58(2):126-32. PubMed ID: 18199163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [25 years allogenic bone marrow transplantation in Basel: 1973-1998].
    Passweg JR; Gratwohl A; Tichelli A; Hoffmann T; Nissen C; Kühne T; Favre G; Avoledo P; Cornu P; Herrmann R; Jeannet M; Osterwalder B; Sartorius J; Schifferli JA; Signer E; Stauffacher W; Speck B
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1568-74. PubMed ID: 9824884
    [No Abstract]   [Full Text] [Related]  

  • 11. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience.
    Jaing TH; Tsay PK; Yang CP; Hung IJ; Wen YC; Tseng CK
    Transplant Proc; 2008 Dec; 40(10):3643-5. PubMed ID: 19100457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and managed care issues in blood and marrow transplantation for hematologic diseases. Report of a symposium, 14 March 1996, Washington, DC.
    Beatty PG
    Exp Hematol; 1997 Oct; 25(11):1195-208. PubMed ID: 9328457
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
    Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
    Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation.
    Armistead PM; Mohseni M; Gerwin R; Walsh EC; Iravani M; Chahardouli B; Rostami S; Zhang W; Neuberg D; Rioux J; Ghavamzadeh A; Ritz J; Antin JH; Wu CJ
    Exp Hematol; 2008 Sep; 36(9):1205-15. PubMed ID: 18550258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
    Ayuk F; Diyachenko G; Zabelina T; Wolschke C; Fehse B; Bacher U; Erttmann R; Kröger N; Zander AR
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):913-9. PubMed ID: 18640575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
    Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
    Br J Haematol; 2009 Aug; 146(3):310-6. PubMed ID: 19508292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.